What to expect at Friday's panel on Pfizer booster shots
An FDA advisory panel will convene in open session Friday to debate the latest booster shot data submitted by Pfizer, and following a non-binding vote, the FDA is expected to formally amend its current vaccine approval for Pfizer.
Opening remarks are set for 8:30 a.m. ET. That's followed by introductions by the FDA, presentations from CDC representatives, discussion of booster protection and a presentation from Pfizer.
After a public hearing portion in the afternoon and a Q&A on the Pfizer and FDA presentations, the committee is expected to debate the issue for about two hours. A vote is expected at about 4:45 p.m. ET.
Next week, the matter heads to the CDC’s independent advisory panel whose members will discuss who should get a booster and when.
-ABC News' Sasha Pezenik